| Valsartan for prevention of recurrent atrial fibrillation GISSI-AF Investigators New England Journal of Medicine 360 (16), 1606-1617, 2009 | 605 | 2009 |
| Anthracycline-induced cardiotoxicity: A multicenter randomised trial comparing two strategies for guiding prevention with enalapril: The International CardioOncology Society … D Cardinale, F Ciceri, R Latini, MG Franzosi, MT Sandri, M Civelli, ... European journal of cancer 94, 126-137, 2018 | 236 | 2018 |
| The emotional response to wine consumption R Ferrarini, C Carbognin, EM Casarotti, E Nicolis, A Nencini, ... Food Quality and Preference 21 (7), 720-725, 2010 | 224 | 2010 |
| Intermittent 6-month low-dose dobutamine infusion in severe heart failure: DICE multicenter trial F Oliva, R Latini, A Politi, L Staszewsky, AP Maggioni, E Nicolis, F Mauri American heart journal 138 (2), 247-253, 1999 | 193 | 1999 |
| Morning and Monday: critical periods for the onset of acute myocardial infaction: The GISSI 2 Study Experience T Gnecchi-Ruscone, E Piccaluga, S Guzzetti, M Contini, N Montano, ... European heart journal 15 (7), 882-887, 1994 | 139 | 1994 |
| Comparative measurement of N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in ambulatory patients with heart failure S Masson, T Vago, G Baldi, M Salio, ND Angelis, E Nicolis, AP Maggioni, ... Walter de Gruyter 40 (8), 761-763, 2002 | 132 | 2002 |
| Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials C Reith, C Baigent, L Blackwell, J Emberson, E Spata, K Davies, H Halls, ... The Lancet 400 (10355), 832-845, 2022 | 131 | 2022 |
| Influence of pentraxin 3 (PTX3) genetic variants on myocardial infarction risk and PTX3 plasma levels E Barbati, C Specchia, M Villella, ML Rossi, S Barlera, B Bottazzi, ... PloS one 7 (12), e53030, 2012 | 71 | 2012 |
| Plasma n-3 polyunsaturated fatty acids in chronic heart failure in the GISSI-Heart Failure Trial: relation with fish intake, circulating biomarkers, and mortality S Masson, R Marchioli, D Mozaffarian, R Bernasconi, V Milani, L Dragani, ... American heart journal 165 (2), 208-215. e4, 2013 | 69 | 2013 |
| Internet for clinical trials: past, present, and future E Santoro, E Nicolis, MG Franzosi, G Tognoni Controlled clinical trials 20 (2), 194-201, 1999 | 65 | 1999 |
| Propranolol for familial cerebral cavernous malformation (Treat_CCM): study protocol for a randomized controlled pilot trial S Lanfranconi, E Scola, GA Bertani, B Zarino, R Pallini, G d’Alessandris, ... Trials 21, 1-10, 2020 | 45 | 2020 |
| Apolipoprotein E polymorphisms influence effect of pravastatin on survival after myocardial infarction in a Mediterranean population: the GISSI-Prevenzione study BD Chiodini, MG Franzosi, S Barlera, S Signorini, CM Lewis, A D'Orazio, ... European heart journal 28 (16), 1977-1983, 2007 | 42 | 2007 |
| Stable isotope ratios and aroma profile changes induced due to innovative wine dealcoholisation approaches B Fedrizzi, E Nicolis, F Camin, E Bocca, C Carbognin, M Scholz, ... Food and Bioprocess Technology 7, 62-70, 2014 | 37 | 2014 |
| Appropriateness of oral anticoagulant therapy prescription and its associated factors in hospitalized older people with atrial fibrillation C Franchi, S Antoniazzi, M Proietti, A Nobili, PM Mannucci, ... British Journal of Clinical Pharmacology 84 (9), 2010-2019, 2018 | 33 | 2018 |
| Safety and efficacy of propranolol for treatment of familial cerebral cavernous malformations (Treat_CCM): a randomised, open-label, blinded-endpoint, phase 2 pilot trial S Lanfranconi, E Scola, JMTA Meessen, R Pallini, GA Bertani, ... The Lancet Neurology 22 (1), 35-44, 2023 | 32 | 2023 |
| Efficacy of n-3 polyunsaturated fatty acids and feasibility of optimizing preventive strategies in patients at high cardiovascular risk: rationale, design and baseline … Rischio and Prevenzione Investigators rep@ marionegri. it Trials 11, 1-8, 2010 | 28 | 2010 |
| Circulating biomarkers and cardiac function over 3 years after chemotherapy with anthracyclines: the ICOS‐ONE trial JMTA Meessen, D Cardinale, F Ciceri, MT Sandri, M Civelli, B Bottazzi, ... ESC Heart Failure 7 (4), 1452-1466, 2020 | 26 | 2020 |
| Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT) X Rossello, S Raposeiras-Roubin, R Latini, A Dominguez-Rodriguez, ... European Heart Journal-Cardiovascular Pharmacotherapy 8 (3), 291-301, 2022 | 24 | 2022 |
| Multiple QTL influence the serum Lp (a) concentration: a genome-wide linkage screen in the PROCARDIS study S Barlera, C Specchia, M Farrall, BD Chiodini, MG Franzosi, S Rust, ... European journal of human genetics 15 (2), 221-227, 2007 | 24 | 2007 |
| Left atrial remodeling and response to valsartan in the prevention of recurrent atrial fibrillation: the GISSI-AF echocardiographic substudy L Staszewsky, M Wong, S Masson, E Raimondi, S Gramenzi, G Proietti, ... Circulation: Cardiovascular Imaging 4 (6), 721-728, 2011 | 22 | 2011 |
